Laboratory of Pharmaceutics and Drug Delivery, Department of Pharmaceutical Science, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
Int J Pharm. 2011 Oct 31;419(1-2):231-4. doi: 10.1016/j.ijpharm.2011.07.007. Epub 2011 Jul 12.
We previously engineered a novel, non-viral, multifunctional gene vector (STR-CH(2)R(4)H(2)C) containing stearoyl (STR) and a block peptide consisting of Cys (C), His (H), and Arg (R). STR-CH(2)R(4)H(2)C forms a nano-complex with pDNA and is stabilized by electronic interactions and disulfide cross linkages. In blood, pDNA, a cytosol-sensitive gene vector, is released from the complex into the cytosol. The current study aimed to make STR-CH(2)R(4)H(2)C capable of active nuclear localization. The dynein light chain association sequence (DLCAS) was disulfide cross-linked to STR-CH(2)R(4)H(2)C/pDNA through disulfide linkages, and the gene expression ability of this DLCAS cross-linked gene vector was evaluated. We examined the gene transfection efficiency of S-180 cells transfected with the STR-CH(2)R(4)H(2)C/DLCAS/pDNA complex. STR-CH(2)R(4)H(2)C/DLCAS/pDNA showed significantly higher and faster gene expression compared with STR-CH(2)R(4)H(2)C/pDNA. We also evaluated the cellular uptake ability of STR-CH(2)R(4)H(2)C/DLCAS/Cy5-labeled pDNA complex. STR-CH(2)R(4)H(2)C/DLCAS/pDNA showed significantly lower cellular uptake compared with STR-CH(2)R(4)H(2)C/pDNA. This result indicates that high gene expression of STR-CH(2)R(4)H(2)C/DLCAS/pDNA does not facilitate its cellular uptake. In addition, the gene expression of DLCAS/STR-CH(2)R(4)H(2)C/pDNA in S-180 cells pretreated with the tubulin polymerization inhibitor, nocodazole (NCZ), was significantly lower than that in the absence of NCZ. These results indicate that the high transfection efficiency of DLCAS/STR-CH(2)R(4)H(2)C/pDNA is dependent on intra-cellular transport utilizing the microtubule motor protein, dynein. Taken together, our results suggest that DLCAS-modified STR-CH(2)R(4)H(2)C may be a promising gene delivery system.
我们之前构建了一种新型的非病毒多功能基因载体(STR-CH(2)R(4)H(2)C),该载体包含硬脂酰基(STR)和由半胱氨酸(C)、组氨酸(H)和精氨酸(R)组成的嵌段肽。STR-CH(2)R(4)H(2)C 与 pDNA 形成纳米复合物,并通过电子相互作用和二硫键交联稳定。在血液中,pDNA,一种细胞质敏感的基因载体,从复合物中释放到细胞质中。本研究旨在使 STR-CH(2)R(4)H(2)C 能够主动核定位。通过二硫键将动力蛋白轻链结合序列(DLCAS)交联到 STR-CH(2)R(4)H(2)C/pDNA 上,评估了这种 DLCAS 交联基因载体的基因表达能力。我们检测了转染 STR-CH(2)R(4)H(2)C/DLCAS/pDNA 复合物的 S-180 细胞的基因转染效率。与 STR-CH(2)R(4)H(2)C/pDNA 相比,STR-CH(2)R(4)H(2)C/DLCAS/pDNA 表现出更高和更快的基因表达。我们还评估了 STR-CH(2)R(4)H(2)C/DLCAS/Cy5 标记的 pDNA 复合物的细胞摄取能力。与 STR-CH(2)R(4)H(2)C/pDNA 相比,STR-CH(2)R(4)H(2)C/DLCAS/pDNA 的细胞摄取明显较低。这一结果表明,STR-CH(2)R(4)H(2)C/DLCAS/pDNA 的高基因表达并不利于其细胞摄取。此外,在紫杉醇聚合抑制剂诺考达唑(NCZ)预处理的 S-180 细胞中,DLCAS/STR-CH(2)R(4)H(2)C/pDNA 的基因表达明显低于无 NCZ 时。这些结果表明,DLCAS/STR-CH(2)R(4)H(2)C/pDNA 的高转染效率依赖于利用微管动力蛋白驱动蛋白的细胞内运输。综上所述,我们的结果表明,DLCAS 修饰的 STR-CH(2)R(4)H(2)C 可能是一种很有前途的基因传递系统。